Autologous transplantation therapy for chronic myelogenous leukemia

Blood. 1997 Apr 15;89(8):2623-34.
No abstract available

Publication types

  • Review

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Bone Marrow Purging
  • Bone Marrow Transplantation*
  • Cells, Cultured
  • Combined Modality Therapy
  • Enzyme Inhibitors / therapeutic use
  • Fusion Proteins, bcr-abl / antagonists & inhibitors
  • Fusion Proteins, bcr-abl / genetics
  • Hematopoietic Stem Cell Transplantation
  • Humans
  • Immunologic Factors / therapeutic use
  • Interferon-alpha / therapeutic use
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / mortality
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / therapy*
  • Oligonucleotides, Antisense / pharmacology
  • Oligonucleotides, Antisense / therapeutic use
  • Protein-Tyrosine Kinases / antagonists & inhibitors
  • Recurrence
  • Survival Analysis

Substances

  • Enzyme Inhibitors
  • Immunologic Factors
  • Interferon-alpha
  • Oligonucleotides, Antisense
  • Protein-Tyrosine Kinases
  • Fusion Proteins, bcr-abl